Incyte Corp
NASDAQ: INCY
$65.74
-$1.08 (-1.6%)
Closing Price on September 20, 2024
INCY Articles
Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from analysts for the coming 12...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Thursday morning. Altria Group Inc. (NYSE: MO) Started as Hold...
Published:
Last Updated:
The three major US stock indexes opened slightly higher this morning, but the DJIA almost immediately turned south and remained in negative territory all session. The Nasdaq composite and S&P 500...
Published:
Last Updated:
The biotech sector has seen its share of ups and downs in 2011 and prior years. It is almost always the case that some of the top performing stocks each year come from this sector due to the...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday morning. Alcoa, Inc. (NYSE: AA) Cut to Neutral from Buy at Goldman Sachs....
Published:
Last Updated:
We have compiled a detailed list of expected upside in the biotech sector. The sector has consolidated and now there is about to be a rush of earnings reports from tomorrow’s emerging drug...
Published:
Last Updated:
2010 is ending and 2011 is about to begin. It has been a very interesting year for major biotech stocks, albeit with lower rewards than seen in 2009 as there have been far fewer ten-baggers with...
Published:
Last Updated:
These are some of this Tuesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Aeropostale, Inc. (NYSE: ARO) Cut to Underweight at KeyBanc. Arris Group Inc....
Published:
Last Updated:
These are this Monday’s top ten analyst upgrades, downgrades, and initiations seen from Wall Street research firms: Biogen Idec (NASDAQ: BIIB) Raised to Buy at Jefferies. Incyte Corporation...
Published:
Last Updated:
Below are some of the top early bird analyst upgrades we have seen early this morning with more than two hours to the open: Freeport-McMoRan (FCX) Raised to Outperform at FBR. Incyte (INCY) Started...
Published:
These are some of the early bird analyst calls we are seeing in stocks this Thursday morning which could impact shares: ADTRAN (ADTN) Raised to Outperform at Baird. Advanced Medical Optics (EYE)...
Published:
It is getting pretty thin in analyst coverage as we get closer to Labor Day, but these are the upgrades and downgrades we are seeing this Wednesday morning: Exponent (EXPO) Started as Buy at...
Published:
Vertex (VRTX-NASDAQ) is seeing quite a bit of trading today ahead of a data presentation tomorrow. This one may have been very active all on its own, but since Dendreon (DNDN-NASDAQ) made its...
Published:
Last Updated: